HemaSphere
(Aug 2023)
PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY
- Xudong Zhang,
- Honghan Qiao,
- Xiaofei Chai,
- Xue Gao,
- Rongjun MA,
- Yufu LI,
- Zunmin Zhu,
- Mingzhi Zhang
Affiliations
- Xudong Zhang
- 1 the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Honghan Qiao
- 1 the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Xiaofei Chai
- 1 the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Xue Gao
- 2 Henan Cancer Hospital, Zhengzhou, China
- Rongjun MA
- 3 Henan Provincial People’s Hospital, Zhengzhou, China
- Yufu LI
- 2 Henan Cancer Hospital, Zhengzhou, China
- Zunmin Zhu
- 3 Henan Provincial People’s Hospital, Zhengzhou, China
- Mingzhi Zhang
- 1 the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- DOI
-
https://doi.org/10.1097/01.HS9.0000976308.74870.ea
- Journal volume & issue
-
Vol. 7
p.
e74870ea
WeChat QR code